Remove Ablation Remove Atrial Fibrillation Remove Atrial Flutter
article thumbnail

Association of typical atrial flutter and cavotricuspid isthmus ablation on clinical recurrence after cryoballoon ablation for atrial fibrillation

Frontiers in Cardiovascular Medicine

Typical atrial flutter commonly occurs in patients with atrial fibrillation (AF). Limited information exists regarding the effects of concurrent atrial flutter on the long-term outcomes of rhythm control. The data were obtained from a multicenter registry of cryoballoon ablation for AF ( n  = 2,689).

article thumbnail

PO-03-120 THE PROGNOSTIC OUTCOME OF ATYPICAL ATRIAL FLUTTER FOLLOWING A SINGLE ELECTROPHYSIOLOGY STUDY AND ABLATION

HeartRhythm

Atypical Atrial Flutter (AAFL) prevalence is increasing due to the escalating Atrial Fibrillation (AF) ablations and cardiac surgeries. We wanted to explore the outcome of the AAFL ablation, considering the recent changes in mapping and ablation.

article thumbnail

Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation

DAIC

Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF. The company now anticipates U.S. Circulation.

article thumbnail

Empirical superior vena cava electrical isolation guided by quantitative ablation index improves outcomes of radiofrequency catheter ablation for paroxysmal atrial fibrillation

Open Heart

Background The value of empirical superior vena cava isolation (SVCI) following pulmonary vein isolation (PVI) to improve the efficacy of radiofrequency catheter ablation (RFCA) for paroxysmal atrial fibrillation (PAF) remains controversial. RFCA was guided by quantitative AI in both groups. vs 81.5%, p=0.02). 95% CI 0.19

article thumbnail

PO-05-111 CLINICAL OUTCOMES OF CATHETER ABLATION FOR ATRIAL FIBRILLATION, ATRIAL FLUTTER, AND ATRIAL TACHYCARDIA IN WILD-TYPE TRANSTHYRETIN AMYLOID CARDIOMYOPATHY: A PROPOSED TREATMENT STRATEGY FOR CATHETER ABLATION IN EACH ARRHYTHMIA

HeartRhythm

Wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM) is often accompanied by atrial fibrillation (AF), atrial flutter (AFL), and atrial tachycardia (AT), which are difficult to control because beta-blockers and antiarrhythmic drugs can worsen heart failure (HF).

article thumbnail

PO-05-118 TRENDS IN CATHETER ABLATION PROCEDURES FOR ATRIAL FIBRILLATION AND ATRIAL FLUTTER IN A FINNISH NATIONWIDE COHORT STUDY

HeartRhythm

Atrial fibrillation (AF) is the most common cardiac arrhythmia with increasing prevalence globally. Catheter ablation is well-established treatment for prevention of AF recurrences and decreasing AF symptoms.

article thumbnail

Atrial dilatation in Atrial fibrillation : A query with multiple twists!

Dr. S. Venkatesan MD

When atrial fibrillation (AF) begins, it can start with a single focus, degenerating to multiple wavelets, and it spreads throughout the entire surface area of both atria. A fibrillatory wave that occurs at a rate of more than 600 beats per minute can cause fatigue in the long run, leading to atrial dilation.